openPR Logo
Press release

Cardiovascular Drugs Market 2024 | AstraZeneca plc, Pfizer, Inc., Sanofi S.A., Merck & Co., Daiichi Sankyo Company Limited, Novartis AG, Bayer AG, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH

11-19-2018 07:57 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Research Report Insights

Cardiovascular Drugs Market 2024 | AstraZeneca plc, Pfizer,

Cardiovascular disorders or heart disorders are disorders of circulatory systems and heart. Inflammatory heart disease, hypertensive heart disease, cerebrovascular heart disease, rheumatic heart disease, and ischemic heart disease fall under the commonly diagnosed cardiovascular disorders. In most cases, the occurrence of high blood pressure leads to hypertensive heart ailments. Major effects of hypertensive heart ailments include hypertrophy, angina, coronary heart disease and heart failure. Similarly, Rheumatic heart disorders are caused by frequent rheumatic fever. In most occasions, Group A streptococcal infection lead to occurring of rheumatic fever.

The disorder is mostly identified in children across the globe, especially in developing economies. Cerebrovascular ailment affects neurones and blood vessels of the brain. Most commonly occurring cerebrovascular disorders include stroke, transient ischemic attack (TIA), vascular dementia, and subarachnoid hemorrhage. Reduced supply of blood to the heart is a major characteristic of Ischemic heart disorders. High death rates have been registered due to ischemic heart disorders, especially in western parts of the globe. While inflammatory heart disorders are caused mainly due to virus or bacterial infections. Such type of disorders is linked with a history of Kawasaki disease or rheumatic fever.

Request For Report Sample: https://www.researchreportinsights.com/report/upsample/120124597/Cardiovascular-Drugs-Market

Factors such as the arrival of newer and advanced drugs and growing prevalence of heart diseases are expected to drive the global cardiovascular drugs market in near future. In addition, higher occurrence of life-style diseases and rise in the global geriatric population is further contributing to the market growth. Moreover, increasing prevalence of chronic diseases such as obesity and diabetes are fueling the demand for cardiovascular drugs.

In contrast, risk of side-effects from cardiovascular drugs and stern regulatory norms are expected to pose challenges for the market growth. Likewise, the expiration of the patent for several blockbuster drugs is an additional factor anticipated to inhibit the growth of global cardiovascular market. Introduction of improved drug combinations and increasing in acquisition and mergers between pharmaceutical companies are key trends governing the global cardiovascular drug market.

Request For Report TOC : https://www.researchreportinsights.com/report/TOC/120124597/Cardiovascular-Drugs-Market

On the basis of drugs, the global cardiovascular drugs market is segmented into anti-dyslipidemics drugs, anti-thrombotics drugs and anti-hypertensive drugs. The Anti-dyslipidemics drug segment is further sub-segment into Tredaptive, Lipitor, Niaspan, Zetia/Vytorin, Crestor, and TriCor/Trilipix. The Anti-hypertensive drug segment is also sub-segmented into Seloken/Toprol-XL, Diovan/Co-Diovan, Benicar/Benicar HCT, Blopress, Aprovel/CoAprovel, Edarbi, Exforge/Exforge HCT, Coversyl, Micardis/Micardis HCT, Tekturna/Rasilez, Cozaar/Hyzaar, and Norvasc. The Anti-thrombotics drug segment includes Lovenox, Plavix, Brilique/Brilinta, Pradaxa, Eliquis and Xarelto.

Key Players:

Some of the key players operating in the cardiovascular disease drug market are AstraZeneca plc, Pfizer, Inc., Sanofi S.A., Merck & Co., Daiichi Sankyo Company Limited, Novartis AG, Bayer AG, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, Astellas Pharma Inc., Johnson & Johnson, United Therapeutics Corporation, Actelion Pharmaceuticals Ltd

Report Analysis: https://www.researchreportinsights.com/report/upcomming/120124597/Cardiovascular-Drugs-Market

About Us
Research Report Insights (RRI) is a leading market intelligence and consulting firm. We deliver a host of services including custom research reports, syndicated research reports, and consulting services which are personalised in nature. RRI delivers a complete packaged solution to clients; this combines current market intelligence, technology inputs, statistical anecdotes, valuable growth insights, 360-degree view of the competitive framework, and anticipated market trends

Contact Us:
Research Report Insights (RRI
42 Joseph Street
Port carling P0B 1J0
Muskoka, Ontario1
Phone - +1-631-721-4201
Website: https://www.researchreportinsights.com
Email: sales@researchreportinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cardiovascular Drugs Market 2024 | AstraZeneca plc, Pfizer, Inc., Sanofi S.A., Merck & Co., Daiichi Sankyo Company Limited, Novartis AG, Bayer AG, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH here

News-ID: 1383088 • Views: 680

More Releases from Research Report Insights

Automotive Brake System Market 5.7% of CAGR throughout 2017-2022 Research Report …
The global automotive brake system market is anticipated to witnessing a substantial growth due to fresh prospects of the automotive industry in emerging along with developing economies and increased safety concerns by the government. It was stated in the report that the overall growth of the market is expected to reach a market value of above US$ 25 Billion through 2022, exhibiting a strong 5.7% of CAGR throughout 2017-2022. In modern
Automotive Brake System Market 2022 | Continental AG, Robert Bosch GmbH, Wabco H …
The global automotive brake system market is anticipated to witnessing a substantial growth due to fresh prospects of the automotive industry in emerging along with developing economies and increased safety concerns by the government. It was stated in the report that the overall growth of the market is expected to reach a market value of above US$ 25 Billion through 2022, exhibiting a strong 5.7% of CAGR throughout 2017-2022. In modern
Tarpaulin Sheets Market These factors, thus, are likely to boost the plastic mar …
A tarpaulin is a big sheet of water-proof material available in various sizes, generally being crafted from plastic like HDPE, LDPE. Tarps can be used to refuge any kind of items. Tarpaulins can efficiently be used to cover goods in the course of shipping and then they also can be used to house goods internal of a truck body so they are not uncovered to the elements. The Tarpaulin Sheets Market
Research Report Insights present kayaks market by 21 percent, or over by $42 mil …
Kayaking is a watersport which involves paddling using a double-bladed oar and a small boat known as a kayak. The boats come in a variety of sizes and types, depending on their intended use, but most kayaks feature an enclosed deck which covers the legs. The boat sits low in the water & usually only accommodates the single paddler, but tandem kayaks hold two people and some boats hold three

All 5 Releases


More Releases for Cardiovascular

Global Cardiovascular Drugs Market
Global Cardiovascular Drugs Market – Industry Analysis and Forecast (2018-2026) – by Drug Class, Indications, Distribution Channels, and Region. Global Cardiovascular Drugs Market was valued at US$ 80.5 Bn in 2017 and is expected to reach US$ 98.8 Bn by 2026, at a CAGR of 2.6 % during the forecast period. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data,
Cardiovascular Drugs Market Detailed Description by 2021
Cardiovascular diseases, also known as heart diseases, are diseases of heart and circulatory system. Some of the most common cardiovascular diseases are hypertensive heart disease, rheumatic heart disease, cerebrovascular heart disease, ischemic heart disease and inflammatory heart disease. Hypertensive heart disease occurs due to high blood pressure. Major problems associated with hypertensive heart disease include heart failure, hypertrophy, coronary heart disease and angina. Rheumatic heart disease is caused by rheumatic
Cardiovascular Drugs Market | Insights
Some of the common cardiovascular diseases include hypertensive heart disease, rheumatic heart disease, ischemic heart disease, inflammatory heart disease, and cerebrovascular heart disease. Major problems associated with hypertensive heart disease include angina, hypertrophy, and heart failure. These problems are caused due to high blood pressure in the heart’s arteries and muscles, which causes narrowing of arteries and thickening and enlargement of heart. The global cardiovascular drug market is primarily driven
Market Overview of Cardiovascular Disease Industry 2018
Albany, NY, 3rd January : Recent research and the current scenario as well as future market potential of "Frontier Pharma: Cardiovascular Disease - Diverse First-in-Class Molecular Targets to Bridge Unmet Needs in Pulmonary Hypertension, Heart Failure and Atherosclerosis" globally. The cardiovascular disease (CVD) therapy area encompasses a range of different diseases and conditions affecting the heart and/or blood vessels. Get PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1313843 The most crucial risk
Medpace Implements Digisonics Solution for Cardiovascular Research
Medpace, a clinical research lab in Cincinnati, has implemented the Digisonics CVIS system for their latest cardiovascular research study. Digisonics provides Medpace’s researchers with unparalleled capabilities for image review and quantitation with over 1,100 preset measurements and an unlimited number of user defined fields as well as the ability to quickly document their findings in a comprehensive report. An additional remote reading application, DigiNet Pro, provides Medpace’s multiple users
Cardiovascular Stents Market — Trends, 2017–2025
When a coronary artery is narrowed by the accumulation of fatty acids, also known as plaque, the blood flow to heart is reduced which result in the chest pain and if the blockage increases the blood flow to the heart is further reduced and might lead to cardiac arrest. To reduce the chances of heart attack, a tiny wire mesh tube is inserted in the artery with a balloon catheter,